To view this email as a web page, go here.

Message below is a paid advertisement. Content is provided by the sponsor.

Provide up to 12 weeks* of flea and tick protection with just one dose.

BRAVECTO® extended flea
and tick protection

No matter how busy life gets, at least you’ll know your patients are protected from fleas & ticks with BRAVECTO^® (Fluralaner).

Fewer doses help improve adherence

More convenient
for pet owners

Four doses of BRAVECTO
provide nearly a full year of flea
and tick protection instead of
having to treat 12 times with
a monthly product.

Fewer potential gaps
in protection^1-4

Fewer doses per year also
means less chance of pet
owners forgetting and
missing one.

Available by
prescription only

Administer the first dose in
your clinic and rest assured
your patient is protected for
up to 12 weeks.*

Prescription-only BRAVECTO delivers up to 12 weeks* of flea and tick protection to dogs and cats with one convenient chew or topical dose. Good for patients, good for compliance and good for your peace of mind.

Contact your Merck Animal Health Rep to order
prescription-only BRAVECTO today.

¹Bravecto Chew for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014.
²Bravecto Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
³Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
⁴Rohdich N, et al. Parasites & Vectors. 2014;7:83.

*BRAVECTO kills fleas and prevents flea infestations for 12 weeks. BRAVECTO Chew and BRAVECTO Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. BRAVECTO Topical Solution for Cats kills ticks (black-legged tick) for 12 weeks and also kills American dog ticks for 8 weeks.

Important Safety Information
Bravecto has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Bravecto Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Use caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures. BRAVECTO Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.

View prescribing Information.

If you no longer wish to receive these e-mails from Merck Animal Health, please unsubscribe here.

Merck Animal Health is committed to protecting your privacy. Information on the collection and use of your personal information may be viewed at www.merck.com/privacy.

This e-mail was sent on behalf of Intervet Inc., Madison, NJ 07940 USA.